WNS (Holdings) Limited (NYSE: WNS), is a leading Business Process Management (BPM) company. We combine our deep industry knowledge with technology and analytics expertise to co-create innovative, digital-led transformational solutions with clients across 10 industries. We enable businesses in Travel, Insurance, Banking and Financial Services, Manufacturing, Retail and Consumer Packaged Goods, Shipping and Logistics, Healthcare, and Utilities to re-imagine their digital future and transform their outcomes with operational excellence.

We deliver an entire spectrum of BPM services in finance and accounting, procurement, customer interaction services and human resources leveraging collaborative models that are tailored to address the unique business challenges of each client. We co-create and execute the future vision of 400+ clients with the help of our 44,000+ employees. Our global footprint spans 16 countries with 61 delivery centers worldwide including in China, Costa Rica, India, the Philippines, Poland, Romania, South Africa, Spain, Sri Lanka, Turkey, United Kingdom and the United States.

Competitive Intelligence, and/or Forecasting in BioTech.

1. Disease overview (varying depth levels)
2. Epidemiology assessments (including incidence and prevalence based modelling)
3. Identification of key patient segments
4. Mapping patient journey
5. Treatment algorithms
6. Identifying unmet needs
7. Competitive landscapes
8. Approval timelines estimation
9. Company profiles
10. Product profiles
11. Label comparisons
12. Market opportunity assessments
13. Clinical trial analytics (Study designs comparisons / Continuous tracking / Results analysis)
14. Conference Intelligence – Offsite [Planners, Tracking] + Onsite [Photo-capturing, Daily summaries, Engaging in conversations with KOL and physicians, Competitors’ Booth Intelligence, etc.]
15. KOL identifications based on multiple parameters
16. News flow tracking
17. Social media monitoring and analytics
18. Desk research on any topic of interest [Generics, Patents, Exclusivity, Special Designations – Orphan/Breakthrough/Fast Track etc. / Price in different geographies / LCM initiatives etc.]
19. Any analysis using the information based on proprietary databases - Citeline, Pharmaprojects, TrialTrove, Evaluate Pharma, Decision Resources, EIKON

B. Pharm/ M. Pharm/ Bachelors (life science)